ORs comparing the proportion with a large future weight gain in quartiles (Q) of five ISPs
| Q2 | Q3 | Q4 | P for trend | |
|---|---|---|---|---|
| Model 1 | ||||
| Fibrinogen | 0.99 | 1.10 | 1.34* | 0.01 |
| Haptoglobin | 0.98 | 1.11 | 1.25 | 0.06 |
| Ceruloplasmin | 1.07 | 1.33* | 1.32* | 0.01 |
| Orosomucoid | 1.03 | 0.96 | 1.36* | 0.02 |
| α1-antitrypsin | 0.97 | 1.14 | 1.27 | 0.02 |
| Model 2 | ||||
| Fibrinogen | 1.00 | 1.07 | 1.28 | 0.046 |
| Haptoglobin | 0.97 | 1.08 | 1.19 | 0.17 |
| Ceruloplasmin | 1.08 | 1.31* | 1.28 | 0.03 |
| Orosomucoid | 1.02 | 0.93 | 1.29* | 0.06 |
| α1-antitrypsin | 0.96 | 1.08 | 1.20 | 0.10 |
* P < 0.05 vs Q1. Reference quartile 1. Model 1, adjusted for age, follow-up time, weight at baseline, and height at baseline and follow-up; model 2, additionally adjusted for physical inactivity at baseline and follow-up, smoking at baseline and follow-up, and high alcohol consumption.